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Abstract
   It is well known that scars, wrinkles, and intraarticular diseases such as rheumatoid arthritis can be 
healed by injecting hyaluronan (HA) into the skin and joints. However, based on its varying molecular 
size, skin penetration of HA may be limited. In this study, we aimed to investigate the effect of transdermal 
enhancements such as electroporation (EP) and iontophoresis (IP) on the in vitro skin permeability of 
HA tetrasaccharide (HA4) to deliver HA4 into skin effectively. The effects of EP and IP on the skin 
permeation of HA4 were studied in in vitro skin permeation experiments. Cumulative amounts of HA4 
through full-thickness skin after 6 h were 0.3 μg/cm2 for passive diffusion, 2.3 μg/cm2 after application 
of EP (100 V, 10 ms, 50 times), 2310.7 μg/cm2 after application of IP (cathodal IP, 0.1 mA/cm2), and 
797.9 μg/cm2 after application of IP (cathodal IP, 0.05 mA/cm2), respectively. The skin permeability 
of the IP (cathodal IP, 0.1 mA/cm2) treatment was about 7700 and 1000-fold increased than that of 
passive diffusion and the EP treatment. The cumulative amount of HA4 through stripped skin after 6 h 
was 1384.3 μg/cm2 for passive diffusion. The skin permeability of the cathodal IP (full-thickness skin, 
0.05 mA/cm2) treatment was about 1.7-fold increased than that of passive diffusion (stripped skin). We 
showed that cathodal IP is useful for delivering HA4 into skin effectively.
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Background
The barrier function of skin is principally attributed to the stratum 
corneum. Only low molecules, usually less than 500 Da, can penetrate 
the skin membrane. Many approaches including chemical enhancers, 
thermal methods, electroporation (EP) [1], iontophoresis (IP) [2,3], 
sonophoresis, laser ablation, and microneedles have been developed 
to enhance the permeability of drugs into the skin by changing the 
stratum corneum microstructure. EP is thought to increase the 
skin permeation of drugs by creating new pores or pathways in the 
stratum corneum. Structural changes induced by EP application to 
the skin are related to the production of water-soluble domains or 
aqueous pathways, which can be applied to the transdermal delivery 
of hydrophilic macromolecules. IP is a process that enhances the 
delivery of drugs through a biological membrane via the application of 
a low-intensity electrical current. IP is the application of an electrical 
potential that maintains a constant electric current across the skin and 
enhances the delivery of drugs.
Hyaluronan (HA) is a large, linear polymer of repeating 
disaccharide units composed of N-acetyl-D-glucosamine and 
D-glucuronic acid. It is a non-sulfated glycosaminoglycan with a 
molecular weight of over 1,000 kDa. HA is a structural component 
of the extracellular matrix in a variety of tissues and plays a key role 
in tissue organization and homeostasis, including angiogenesis, 
branching morphogenesis, cell migration, and cell proliferation [4-6]. 
It is well known that scars and wrinkles can be healed by injecting HA 
into the skin. The analgesic effects of intraarticular injection of HA 
have been immensely beneficial to patients with joint diseases such 
as osteoarthritis or rheumatoid arthritis. However, It may do bacterial 
infection by the needle while it has the advantage that it is treatment 
in a short amount of time. In contrast, IP and EP of HA were used 
for non-invasive treatment. Therefore, advantage of use of IP and EP 
were little worry of the infection. Based on its varying molecular size, 
the skin passive penetration of HA may be limited. We focused our
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attention on a HA tetrasaccharide (HA4) containing two units, with 
a single unit being N-acetyl-D-glucosamine and D-glucuronic acid. 
Our group previously reported that HA4 permeated through the skin
by passive diffusion [7]. The purpose of this work was to study the 
effect of EP and IP on the in vitro skin permeability of HA4 across 
hairless mice skin to deliver HA4 into skin effectively.
Materials & Methods
Materials
HA4 (99.14%) (776.3 Da) was used by Glycoscience Laboratories 
Inc. (Tokyo, Japan). All other chemicals and solvents used were 
analytical grade.
Animals
Male hairless mice (HR-1, 7 weeks old, body weight: 23-30 g) were 
purchased from Hoshino Experiment Animal Center (Ibaraki, Japan).
They were housed in rooms where the lighting was automatically 
regulated on a 12 hour light and dark cycle. All experimental animals
had free access to food and water. Every animal experiment was 




Madoka Kage and Yoshihiro Tokudome*
Laboratory of Dermatological Physiology, Faculty of Pharmaceutical Sciences, Josai University, 1-1 Keyakidai, Sakado, Saitama, 350-0295, Japan
Int J Pharma Sci Res                                                                                                                                                                                                 IJPSR, an open access journal 
ISSN: 2394-1502                                                                                                                                                                                                        Volume 3. 2016. 113                                        
                                      Kage et al., Int J Pharma Sci Res 2016, 3: 113
                                      http://dx.doi.org/10.15344/2394-1502/2016/113  
Abbreviations
HA: Hyaluronan, HA4: Hyaluronan tetrasaccharide, EP: Electroporation, IP: Iontophoresis
Int J Pharma Sci Res                                                                                                                                                                                                 IJPSR, an open access journal 
ISSN: 2394-1502                                                                                                                                                                                                        Volume 3. 2016. 113            
In Vitro HA4 Permeation Experiments
Permeation studies were conducted with excised intact hairless 
mouse skin (8-12 weeks old) as a diffusion membrane. To obtain 
stripped skin, adhesive tape was applied to hairless mouse skin with 
uniform pressure until the stratum corneum was entirely removed 
from the skin. A vertical diffusion cell used and study conditions 
were the same as those previously described [7]. Donor solution 
was applied with 1 mL of distilled water containing 0.5 % HA4 for 
each. The receiver solution was distilled water (passive and EP) or 
phosphate-buffered saline (IP).
Application of Electroporation
Plate type Ag electrodes (0.04 mm thickness) were made from 
silver rods and plates (Murata Yohaku, Tokyo, Japan), respectively, 
in our laboratory. Plate electrodes passed on electrically insulated 
doublefaced adhesive tape. The membrane with the peripheral 
adhesive layer had a 5.0 mm distance between both plate electrodes 
to make an electrode membrane at the donor side. A pulse generator 
(ECM 820, BTX, San Diego, CA, USA) was used to apply voltage 
50 times (one pulse every second). The pulse voltage and duration 
were 100 V and 10 ms, respectively. This EP treatment was generally 
conducted at time zero for skin permeation experiments.
Application of Iontophoresis
A constant current was applied through Ag/AgCl electrodes, 
connected to a constant current generator (IP-50K, Ito Co., Ltd., 
Tokyo, Japan). A current density of 0.05 and 0.1 mA/cm2 was applied 
for 6 h. The donor chamber held either the anode or cathode in two 
separate sets of experiments in anode-to cathode (anodal IP) or 
cathode-to anode (cathodal IP) directions.
Determination of HA4
The determination of HA4 was performed using a LC/MS system 
(LCQ DECA XP plus, Thermo Fisher Scientific Inc., MA, USA). The 
electrospray interface, LC/MS separation, and flow rate were the same 
as previously reported [7].
Results and Discussion
The effects of EP and IP on the skin permeation of the 0.5 % HA4 
solution were investigated in in vitro skin permeation experiments. 
It has been reported that plate-plate EP electrodes showed higher 
permeation of drugs than other electrodes [8]. For this reason, EP 
was applied using plate-plate electrodes in this study. Cumulative 
amounts of HA4 through full-thickness skin after 6 h were 0.3 ± 
0.1 μg/cm2 for passive diffusion (Figure 1), 2.3 ± 0.9 μg/cm2 after 
application of EP (100 V, 10 ms, 50 times), respectively (Table 1). The 
skin permeability of the EP treatment was about 8-fold increased than 
that of passive diffusion. In addition, the cumulative amount of HA4 
for 6 h was 2310.7 ± 703.1 μg/cm2 after the application of IP (cathodal 
IP, current density: 0.1 mA/cm2) (Table 1). The skin permeability 
of the IP treatment was about 7700-fold increased than that of 
passive diffusion and about 1000-fold increased than that of the EP 
treatment. The flux and permeability coefficient of the IP treatment 
was increased than that of the EP treatment (Table 1). EP is thought 
to increase the skin permeation of drugs by creating new pores or 
pathways in the stratum corneum. In contrast, IP enhances drug 
delivery across the skin by electrorepulsion and electroosmosis. IP 
employs an electrical potential gradient as the driving force to enhance 
the permeability of charged and polar drug molecules. This study 
demonstrated that skin permeation of HA4 was enhanced more by 
IP than that by EP.  This may have a great influence on the driving 
force. The amount of small peptide like arginine-vasopressin (1084.2 
Da) permeating through rat skin with the IP treatment was increased 
than that with passive diffusion, and flux depended on the magnitude 
of current density [9].  The effect of current density on the transport 
of HA4 was investigated in in vitro skin permeation experiments by 
cathodal IP.  Cumulative amounts of HA4 permeated after 6 h were 
797.9±79.0 μg/cm2 at 0.05 mA/cm2 current density and 2310.7±703.1 
μg/cm2 at 0.1 mA/cm2 current density, respectively (Figure 1 and 
Table 1).  The skin permeation of HA4 depended on the magnitude of 
current density.  In addition, the cumulative amount of HA4 permeated 
after 6 h was 2.0±0.1 μg/cm2 for anodal IP (current density: 0.1 mA/
cm2) (Table 1). The skin permeation of the cathodal IP treatment was 
about 1200-fold enhanced than that of the anodal IP treatment.  The 
delivery of HA4 into the skin was enhanced more by the cathodal IP 
treatment than that by the anodal IP treatment because the effects of 
IP on the skin permeation of HA4 of anionic compounds contributed 
to electrorepulsion.  The barrier function of the skin is principally 
attributed to the stratum corneum.  The cumulative amount of HA4 
through stripped skin after 6 h was 1384.3±32.8 μg/cm2 (Figure 1). 
Skin permeability by passive diffusion was about 4600-fold increased 
in stratum corneum stripped skin than that of full-thickness 
skin.  In addition, the cumulative amount of HA4 permeated after 
6 h by cathodal IP (current density: 0.05 mA/cm2) was about 1.7-
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Figure 1.  Permeation Profile of the Cumulative Amount of HA4 
Each point represents mean ± S.D. of 3 to 4 determinations.  Symbols: 
passive (full-thickness skin) (0), passive (stripped skin) ( ), cathodal IP 
(current density: 0.05 mA/cm2) (☐) and cathodal IP (current density: 0.1 
mA/cm2) (■).
Conditions Cumulative 









Passive Stripped skin 1384.3±32.8 418.0±30.6 23.2±1.7
EP 100 V, 10 ms, 
50 times
2.3±0.9 0.7±0.3 0.04±0.02
Anodal IP 0.1 mA/cm2 2.0±0.1 0.2±0.1 0.01±0.007
Cathodal IP 0.1 mA/cm2 2310.7±703.1 656.2±197.5 36.5±11.0
Cathodal IP 0.05 mA/cm2 797.9±79.0 236.7±29.8 13.2±1.7
Table 1:  Influence of Various Conditions on the Permeation of HA4 
through Hairless Mice Skin.
fold increased than that of stripped skin by passive diffusion.
HA has a pronounced hydrophilic capacity and high molecular 
size polysaccharides; therefore, skin permeation may be limited. 
Therefore, HA injection therapy is used in cosmetic and medical 
fields.  By contrast, we show that HA4 permeated through the skin by 
passive diffusion, and cathodal IP was useful for delivering HA4 into 
skin effectively. Our group previously reported that HA4 enhanced 
the hyaluronan and collage type I synthesis [10], keratinocyte 
differentiation [11] and ceramide production [12], and thereby can 
be involved in the skin functional recovery after UVA irradiation. 
HA4 delivery into skin by IP may be useful in producing these actions 
noninvasively.
Conclusion
We showed that cathodal IP is useful for delivering HA4 into skin 
effectively.
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